Drugs in development
Psoriasis research is benefiting from the fact that psoriasis is driven by the immune system and responds to drugs that suppress the body's immune response. Because psoriasis is easily visible on the skin, the disease provides an excellent model for studying the effectiveness of various medications that might be useful in other diseases that involve the immune system, such as diabetes, lupus and rheumatoid arthritis.
Basic medical research is funded by taxes mostly in the public sector and investments and cash generated in the private sector. This research is responsible for launching many new drugs. In fact, most drugs can be traced to scientific discoveries that took place in basic science research labs. This basic research becomes the basis for new drugs and therapies, which are tested in clinical trials and submitted to the federal government for approval. Years later, the process ends when new drugs reach the market.
Learn More